Effect of eliminating priority points for HLA-B matching on racial disparities in kidney transplant rates

Erin C Hall1, Allan B Massie, Nathan T James

  • 1Department of Surgery, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA.

Insights

The 2003 kidney allocation policy change reduced, but did not eliminate, the disparity in deceased donor kidney transplants (DDKT) for African Americans compared to whites. Further changes are needed to achieve transplant equity.

Area of Science:

  • Nephrology
  • Transplantation Immunology
  • Health Services Research

Background:

  • African Americans experience lower rates of deceased donor kidney transplants (DDKT) compared to white individuals.
  • Differential HLA (Human Leukocyte Antigen) distributions are a proposed factor contributing to this disparity.
  • A 2003 policy change removed HLA-B matching priority to address racial disparities in kidney allocation.

Purpose of the Study:

  • To quantify the impact of the 2003 kidney allocation policy change on HLA-B matching priority.
  • To assess the effect of this policy change on the disparity in DDKT rates between African Americans and whites.

Main Methods:

  • An observational cohort study analyzed 178,902 patients awaiting DDKT from January 2000 to August 2009.
  • Cox models were used to compare DDKT rates between African Americans and whites before and after the policy change, adjusting for key demographic and clinical factors.
  • Transplant rates were measured as time from waitlisting to DDKT, censored for living donor transplant or death.

Main Results:

  • Before the policy change, African Americans had 37% lower DDKT rates (aRR, 0.63) compared to whites.
  • After the policy change, African Americans had 23% lower DDKT rates (aRR, 0.77) compared to whites.
  • The policy change resulted in a 23% reduction in the racial disparity, but did not achieve parity.

Conclusions:

  • The HLA-B policy change decreased the racial disparity in DDKT rates but did not eliminate it.
  • Unaddressed factors in kidney allocation continue to contribute to disparities for African Americans on the transplant waiting list.
  • Further research and policy interventions are necessary to achieve equitable kidney transplant access.
Abstract

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...